St. Jude Children's Research Hospital
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.stjude.org/
Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen
- Conditions
- Hematological Malignancies
- Interventions
- Biological: G-CSFRadiation: Total lymphoid irradiationBiological: Lymphocyte infusionsDevice: CliniMACS
- First Posted Date
- 2014-07-24
- Last Posted Date
- 2018-02-07
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT02199041
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
The Good Patient Study
- Conditions
- Solid TumorHematological MalignanciesBrain Tumor
- Interventions
- Other: Interview
- First Posted Date
- 2014-07-24
- Last Posted Date
- 2015-06-04
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 43
- Registration Number
- NCT02199548
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸Children's National Health System, Washington, District of Columbia, United States
Feasibility of Generating Pluripotent Stem Cells From Patients With Familial Retinoblastoma
- Conditions
- Retinoblastoma
- Interventions
- Other: Skin BiopsyOther: Blood Draw
- First Posted Date
- 2014-07-18
- Last Posted Date
- 2020-10-23
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT02193724
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody
- Conditions
- Ewing Family of TumorsOsteosarcomaMelanomaNeuroblastoma
- First Posted Date
- 2014-06-10
- Last Posted Date
- 2020-11-05
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 76
- Registration Number
- NCT02159443
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Medication Adherence in Youth With Sickle Cell Disease (SCD)
- Conditions
- Sickle Cell Disease
- Interventions
- Behavioral: Demographic QuestionnaireBehavioral: Medical Adherence Measure QuestionnaireBehavioral: Acceptability Questionnaire
- First Posted Date
- 2014-05-20
- Last Posted Date
- 2015-05-27
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT02143076
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
- Conditions
- NeuroblastomaLymphomaHigh-risk Tumor
- Interventions
- Biological: CD133+ selected autologous stem cell infusionBiological: IL-2Biological: hu14.18K322ABiological: GM-CSFDevice: Haploidentical natural killer cell infusionBiological: G-CSFDevice: CliniMACS
- First Posted Date
- 2014-05-06
- Last Posted Date
- 2017-12-22
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT02130869
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma
- Conditions
- Ependymoma
- Interventions
- Radiation: IrradiationProcedure: SurgeryDrug: ^1^8F-FluorodeoxyglucoseDrug: ^1^1C-methionineDevice: Photon therapyDevice: Proton therapy
- First Posted Date
- 2014-04-29
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 68
- Registration Number
- NCT02125786
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Medication Adherence in Human Immunodeficiency Virus (HIV)
- Conditions
- Human Immunodeficiency Virus
- Interventions
- Other: Demographic QuestionnaireBehavioral: Staff-delivered intervention sessionsOther: Questionnaires
- First Posted Date
- 2014-04-21
- Last Posted Date
- 2016-08-02
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 33
- Registration Number
- NCT02119390
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
- Conditions
- Atypical Teratoid Rhabdoid TumorMalignant Rhabdoid Tumor
- Interventions
- Procedure: Surgical resectionRadiation: Radiation therapy
- First Posted Date
- 2014-04-15
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 125
- Registration Number
- NCT02114229
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
🇺🇸Lucille Packard Children's Hospital at Stanford University Medical Center, Palo Alto, California, United States
Sickle Cell Clinical Research and Intervention Program
- Conditions
- Sickle Cell Disease
- First Posted Date
- 2014-03-28
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT02098863
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸Children's Hospital of Illinois at OSF-Saint Francis Medical Center, Peoria, Illinois, United States
🇺🇸Regional One Health, Diggs-Kraus Sickle Cell Center, Memphis, Tennessee, United States